DUBLIN, Sept. 14, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced clinical study results of higher doses of BOTOX ® Cosmetic compared to BOTOX ® Cosmetic 20 unit dose at week 24 in ...

Please provide your email address to receive an email when new articles are posted on . New phase 2 results showed 40 units of Jeuveau sustained improvements in glabellar lines up to 6 months. Adverse ...

The US Food and Drug Administration (FDA) has approved daxibotulinumtoxinA-lanm injection (Daxxify) for the temporary improvement in the appearance of moderate to severe glabellar lines (frown lines) ...

Botulinum toxin A is a naturally occurring compound made by bacteria that’s found in the environment. There are several commercially available products on the market, such as Botox, Dysport, Xeomin ...

Botox, or botulinum toxin, might be most popularly known as a treatment for wrinkles; it's a neurotoxic agent produced by Clostridium botulinum bacteria, and works by causing a mild, local paralysis.

Shares of Allergan plcAGN were down almost 4% on Monday after Evolus, Inc. EOLS announced FDA approval for its lead product, Jeuveau injection on Feb 1. The injection is indicated for the improvement ...

–TrenibotE is a first-in-class botulinum neurotoxin serotype E characterized by a rapid onset of action as early as 8 hours after administration (earliest assessment time) and shorter duration of ...

Move over, Botox — there’s a new skin-jectable on the block, and it lasts even longer. Seriously. Enter: Daxxify, otherwise known as Daxi, and short for the more formal term, DaxibotulinumtoxinA-lanm.

SACRAMENTO (CBS13) - Mark your calendars, National Botox Cosmetic Day is November 20th. Allergan, which is the parent company of Botox, declared the holiday in order to celebrate its injectable ...